Schedule 13D ownership disclosure
MARKER THERAPEUTICS ORD
Security class unavailable · CUSIP: 57055L107
Event date: 2018-10-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,261,853
- Percent of class
- 17.3700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-19-007747
- Form type
- SC 13D
- Filer
- Marker Therapeutics, Inc.
- CIK
- CIK 1094038
- Filed
- Feb 14, 2019
- Reporting period
- Oct 17, 2018
- Description
- Schedule 13D beneficial ownership